Found 7 obstetrics-and-gynecology trials
A listing of obstetrics-and-gynecology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
K
KRISTI M. LELIONIS
FIT-PLESE is a research study to find out the effects of lifestyle modification in obese women with unexplained infertility. Eligible participants will be randomized to either an Intensive Lifestyle Modification Program or a Standard Physical Activity Program for 16 weeks, followed by fertility treatment with ovarian stimulation and intrauterine insemination.
MOXI is a research study to examine whether antioxidants can improve abnormal semen parameters in couples with male-factor infertility. Eligible male participants will be randomized to either an antioxidant supplement or placebo for 3 months, followed by fertility treatment with ovarian stimulation and intrauterine insemination.
Healthy women ages 18-45 with Polycystic Ovary Syndrome (PCOS) are invited to screen for a study participation in an investigational drug study
The Women's Health Clinical Research Center at University of Pennsylvania is currently recruiting healthy women who have regular periods for a research study of an investigational birth control ring. The study ring that will be used in this study is experimental and being developed as a possible new method of …
The UNTIL Trial is a new clinical research trial that offers uterine transplantation to women with uterine factor infertility (UFI). Participation in this trial requires going through an extensive selection process, creation of embryos through in vitro fertilization, and multiple surgeries. Study participants may remain in the study for 5-10 …
OCPs increase the risk of MetS specifically by producing an atherogenic lipoprotein phenotype, increasing blood pressure and/ or body weight while metformin modestly decreases MetS risk by decreasing body weight and improving lipid phenotype. The combination of OCP and metformin (OCP, through lowering androgens, and metformin, through improvement in insulin …
Healthy women 18 to 50 years of age who are seeking treatment for heavy menstrual bleeding and do not wish to become pregnant during the next ten months are invited to participate.
